Furthermore, metabolic effects, such as the lowering of hemoglobin A1c (HbA1c) in patients with ischemic heart disease and diabetes [31,32,33], or the improvement of insulin secretion and β-cell survival in diabetic mice [34], have already been described. The gene discussed is INS; the disease is diabetes mellitus.